Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-23-006401

Options or other derivatives

  • Chief Medical Officer acquired 225,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Smith Karen L. Chief Medical Officer 2023-02-01 Grant or award · Employee Stock Option (right to buy) +225,000 225,000 D
Loading xslF345X03/doc4.xml…